Humana Inc. (NYSE:HUM) Shares Purchased by XTX Topco Ltd

XTX Topco Ltd increased its stake in shares of Humana Inc. (NYSE:HUM) by 111.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,435 shares of the insurance provider’s stock after acquiring an additional 1,810 shares during the period. Humana comprises 0.3% of XTX Topco Ltd’s holdings, making the stock its 15th largest position. XTX Topco Ltd’s holdings in Humana were worth $1,668,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. MV Capital Management Inc. grew its holdings in Humana by 40.8% in the first quarter. MV Capital Management Inc. now owns 69 shares of the insurance provider’s stock valued at $33,000 after purchasing an additional 20 shares during the period. Householder Group Estate & Retirement Specialist LLC acquired a new stake in Humana in the first quarter valued at approximately $39,000. Delta Asset Management LLC TN acquired a new stake in Humana in the fourth quarter valued at approximately $46,000. Key Financial Inc grew its holdings in Humana by 130.4% in the first quarter. Key Financial Inc now owns 106 shares of the insurance provider’s stock valued at $52,000 after purchasing an additional 60 shares during the period. Finally, Trustcore Financial Services LLC grew its holdings in Humana by 49.4% in the fourth quarter. Trustcore Financial Services LLC now owns 115 shares of the insurance provider’s stock valued at $59,000 after purchasing an additional 38 shares during the period. 91.86% of the stock is owned by institutional investors and hedge funds.

Humana Trading Down 0.9 %

HUM opened at $467.73 on Friday. Humana Inc. has a 12 month low of $423.29 and a 12 month high of $571.30. The stock has a market capitalization of $57.96 billion, a price-to-earnings ratio of 17.45, a PEG ratio of 1.20 and a beta of 0.66. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.37 and a quick ratio of 1.37. The business has a fifty day moving average price of $465.41 and a 200 day moving average price of $488.12.

Humana (NYSE:HUM) last released its earnings results on Wednesday, August 2nd. The insurance provider reported $8.94 EPS for the quarter, topping the consensus estimate of $8.88 by $0.06. Humana had a return on equity of 20.70% and a net margin of 3.42%. The firm had revenue of $26.75 billion during the quarter, compared to analysts’ expectations of $25.83 billion. During the same period in the previous year, the firm posted $8.67 EPS. Humana’s revenue for the quarter was up 13.0% on a year-over-year basis. Sell-side analysts expect that Humana Inc. will post 28.25 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 29th will be given a dividend of $0.885 per share. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $3.54 dividend on an annualized basis and a yield of 0.76%. Humana’s payout ratio is 13.21%.

Wall Street Analysts Forecast Growth

Several analysts have commented on HUM shares. Argus lowered Humana from a “buy” rating to a “hold” rating in a report on Friday, June 23rd. TD Cowen reduced their price objective on Humana from $616.00 to $613.00 and set an “outperform” rating on the stock in a research report on Tuesday, August 15th. StockNews.com initiated coverage on Humana in a research report on Thursday, August 17th. They set a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft lifted their target price on Humana from $468.00 to $628.00 and gave the company a “buy” rating in a research report on Monday, August 7th. Finally, Morgan Stanley reduced their target price on Humana from $637.00 to $624.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 30th. Four equities research analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. Based on data from MarketBeat.com, Humana presently has a consensus rating of “Moderate Buy” and a consensus price target of $592.30.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.